About this trial
Drug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment has shown promise as a possible way to reduce seizures, but it has not been tested in humans for this. The investigators are interested to know if it can reduce seizures, and how comfortable it is to be treated with this therapy.
Eligibility criteria
Qualifiers
Drug resistant epilepsy
Age 18 or older
Average seizure rate of at least 2 seizures per month
Accurate seizure diary with at least 3 months recorded
Disqualifiers
Implanted intracranial neurostimulation device (DBS or RNS)
Intracranial shunt
Skin photosensitivity
Cancer on scalp
Trial design
Treatments tested in this trial
- photobiomodulation